ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER pharmaceutical API fine chemical suppliers

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek	⤷ Start Trial	9570985	⤷ Start Trial
BOC Sciences	⤷ Start Trial	104376-79-6	⤷ Start Trial
Hello Bio	⤷ Start Trial	HB0176	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 14, 2025

Introduction

The pharmaceutical industry’s reliance on high-quality Active Pharmaceutical Ingredients (APIs) is fundamental to ensuring safety, efficacy, and regulatory compliance in injectable antibiotics such as ROCEPHIN (ceftriaxone sodium) combined with dextrose. This presentation identifies primary suppliers and key considerations for sourcing bulk APIs, emphasizing quality standards, regulatory approvals, and supply chain reliability.

Overview of ROCEPHIN and API Composition

ROCEPHIN (ceftriaxone sodium) is a third-generation cephalosporin antibiotic used for serious bacterial infections. When supplied in a plastic (typically polyethylene or polypropylene) container with dextrose, it provides a ready-to-use intravenous formulation. The API—ceftriaxone sodium—must meet stringent pharmaceutical standards. Dextrose is a readily available excipient, but the API component's source remains central to manufacturing quality.

Global API Manufacturing Landscape

The bulk API supply chain for ceftriaxone sodium is concentrated among established manufacturers primarily based in:

India: The leading supplier with a significant share of global ceftriaxone production.
China: Increasing presence in pharmaceutical intermediates and APIs.
Europe and the U.S.: Smaller but critical for high-value or specialty APIs requiring stringent regulatory oversight.

This distribution aligns with the broader trend of Asia dominating global pharmaceutical intermediates, reinforcing factors like cost-effectiveness, manufacturing capacities, and regulatory approval status.

Top API Suppliers for Ceftriaxone Sodium

1. Indian Manufacturers

a. MNCs and Established Indian Manufacturers

Shilpa Medicare Ltd.
Recognized for high-quality APIs compliant with international standards such as USFDA, EMA, and WHO-GMP. Their ceftriaxone sodium API is validated for injectable formulations, with global certifications ensuring reliability.
Hetero Labs Ltd.
Offers consistent API quality with proven manufacturing practices suitable for sterile injectable formulations. Their facilities are approved by multiple regulatory agencies, supporting export to regulated markets.
Glenmark Pharmaceuticals
Known for integrating API production with finished formulations, providing end-to-end supply chain assurance and adherence to Good Manufacturing Practices (GMP).

b. Contract Manufacturing Organizations (CMOs)

Several Indian CMOs, such as Aurobindo Pharma and Cipla, manufacture ceftriaxone sodium API designed for bulk export and domestic use, often certified for WHO-GMP and other international standards.

2. Chinese API Manufacturers

Companies like North China Pharmaceutical Group and Hicorp Pharmaceutical supply ceftriaxone sodium with growing validation for US and European markets.
Chinese API producers often offer competitive pricing, but buyers should verify compliance with rigorous quality standards and international regulatory approvals.

3. European and American Suppliers

EuroAPI (former part of Novartis) and other North American entities provide high-purity ceftriaxone sodium APIs suited for highly regulated markets, albeit at higher costs.
These manufacturers typically adhere to stricter cGMP standards, ensuring minimal impurities and consistency.

Regulatory and Quality Considerations

GMP Certification: Ensure API suppliers comply with Good Manufacturing Practices as per WHO, EMA, or FDA standards.
Regulatory Approvals: Verify registration or approvals from local health authorities for APIs intended for injectable therapeutic formulations.
Batch Consistency & Purity: The API must demonstrate consistent potency, low endotoxin levels, and minimal impurities, confirmed via batch testing reports and certificates of analysis (COA).
Supply Chain Reliability: Evaluate supplier capacity, lead times, and contingency planning, especially given global supply disruptions.

Key Criteria in Sourcing API for ROCEPHIN w/ Dextrose

Criteria	Details
Compliance Standards	USFDA, EMA, WHO-GMP certifications
Purity & Potency	≥98% purity, validated potency
Impurity Profile	Low levels of known impurities; compliance with pharmacopeial limits
Manufacturing Capacity	Ability to meet large-scale demand
Pricing & Delivery	Competitive pricing balanced with quality assurance

Emerging Trends and Challenges

Regulatory Stringency: Increased scrutiny in validation and documentation for APIs.
Supply Chain Disruptions: COVID-19 and geopolitical issues have highlighted vulnerabilities, underscoring the importance of diversified sourcing.
Quality Verification: Due diligence on API sources through audits, third-party testing, and supplier audits remains critical.
Sustainability and Ethical Sourcing: Growing emphasis on environmentally responsible manufacturing practices.

Conclusion

Securing a reliable source of ceftriaxone sodium API for formulations like ROCEPHIN in plastic containers requires careful evaluation of regulatory compliance, manufacturing quality, and supply capacity. Indian manufacturers represent a significant portion of the global market, offering a blend of cost-effective, high-quality products with extensive regulatory approval. Chinese suppliers are increasingly conforming to international standards, providing competitive alternatives. High-end European and American API producers prioritize stringent quality, albeit with higher costs.

Strategic partnerships with reputable suppliers—verified through audits, certifications, and batch testing—are paramount for ensuring product integrity, regulatory compliance, and uninterrupted supply.

Key Takeaways

Indian API manufacturers such as Shilpa Medicare and Hetero offer high-quality ceftriaxone sodium APIs with strong global certifications.
Robust regulatory compliance, including WHO-GMP and FDA approvals, is essential for sourcing APIs intended for injectable formulations.
Supply chain diversification minimizes risks of disruption; engaging multiple validated suppliers is advisable.
Continuous quality verification through testing, audits, and documentation is critical for maintaining API integrity.
Emerging geopolitical and economic factors necessitate proactive sourcing strategies aligned with regulatory landscapes.

FAQs

1. What are the primary factors to consider when selecting an API supplier for ROCEPHIN?
Regulatory compliance, API purity and potency, manufacturing capacity, supply reliability, and cost-effectiveness.

2. Are Indian and Chinese ceftriaxone sodium APIs compliant with Western regulatory standards?
Many Indian and Chinese manufacturers have achieved certifications such as WHO-GMP, USFDA, or EMA approvals, but due diligence is essential to confirm current compliance status.

3. How does supply chain disruption affect API sourcing?
Disruptions can lead to shortages, delays, and increased costs, emphasizing the need for diversified sourcing and strategic inventory management.

4. What quality standards should I verify before importing ceftriaxone sodium API?
Ensure compliance with pharmacopoeial standards (USP, EP, JP), GMP certification, detailed Certificates of Analysis, and validated impurity profiles.

5. Is it necessary to conduct audits of API manufacturers?
Yes, especially for high-volume or regulated markets. Audits ensure compliance with quality standards and verify manufacturing practices.

Sources:
[1] Indian Pharmaceutical Industry Overview, IQVIA Reports, 2022.
[2] WHO Guidelines on Quality Assurance of Active Pharmaceutical Ingredients, 2020.
[3] USFDA Approved Drug Master Files (DMFs).
[4] European Medicines Agency (EMA) Certification Reports.
[5] Recent Trends in API Manufacturing and Supply Chain Resilience, Pharmaceutical Technology, 2023.

Bulk Pharmaceutical API Sources for ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER